Cargando...
Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
BACKGROUND: Concern for the development of extrapyramidal side effects (EPSEs) represents a barrier to the routine use of long-acting injectable (LAI) antipsychotic medication in patients with first-episode schizophrenia (FES). Flupenthixol decanoate is a first-generation antipsychotic, which is rea...
Gardado en:
| Publicado en: | S Afr J Psychiatr |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
AOSIS
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7876946/ https://ncbi.nlm.nih.gov/pubmed/33604077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4102/sajpsychiatry.v27i0.1568 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|